DarioHealth Hits 100 Studies, Strengthening Evidence-Based Digital Health Position

Event summary

  • DarioHealth has surpassed 100 peer-reviewed scientific studies, including journal publications and conference abstracts.
  • The studies cover large populations, longitudinal designs, and multi-condition evaluations.
  • Research includes independent, third-party investigator-initiated studies.
  • Key outcomes measured include actual claims reduction and HbA1c improvement.
  • Milestone achieved on January 21, 2026.

The big picture

As healthcare purchasers prioritize value-based decision-making, DarioHealth's 100-study milestone positions it as a leader in evidence-based digital health. The company's focus on measurable outcomes aligns with industry shifts toward vendor consolidation and demand for scientifically validated solutions. This strategic advantage could accelerate adoption across cardiometabolic, behavioral health, and musculoskeletal conditions.

What we're watching

Evidence Demand
How the growing emphasis on measurable outcomes will affect digital health vendor selection.
Vendor Consolidation
Whether DarioHealth's research portfolio can drive broader adoption and partnerships.
Multi-Condition Impact
The pace at which integrated care solutions gain traction in employer and health plan contracts.